Clinical Study
Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial
Table 1
Patient demographics.
| | | TTX () | Placebo () |
| | Age (years) | | | | | 77 | 88 | | Mean (SD) | 55.5 (11.2) | 54.8 (11.5) | | Gender, (%) | | | | | 77 | 88 | | Male | 27 (35.1) | 44 (50.0) | | Female | 50 (64.9) | 44 (50.0) | | Race, (%) | | | | | 77 | 88 | | Caucasian | 72 (93.5) | 84 (95.5) | | Asian | 1 (1.3) | 1 (1.1) | | African American | 1 (1.3) | 0 (0.0) | | Other | 3 (3.9) | 3 (3.4) | | Height (cm) | | | | | 71 | 78 | | Mean (SD) | 165.8 (9.6) | 168.4 (8.9) | | Weight (kg) | | | | | 72 | 77 | | Mean (SD) | 73.4 (18.3) | 78.2 (19.1) | | BMI (kg/m2) | | | | | 70 | 76 | | Mean (SD) | 26.7 (5.4) | 27.4 (5.9) |
|
|
BMI: body mass index; SD: standard deviation.
|
